ACG Group
ACG Group is an India-based multinational supplier of pharmaceutical manufacturing, packaging, capsule, inspection, and anti-counterfeiting technologies.
Last updated August 31, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
ACG Group is a multinational pharmaceutical machinery and materials company headquartered in Mumbai, India. Founded in 1961 by brothers Ajit Singh and Jasjit Singh, the company began by manufacturing empty hard capsules for Indian pharmaceutical companies. It later expanded internationally and developed a broader portfolio serving pharmaceutical and nutraceutical manufacturers, including capsule shells, specialty films and foils, oral solid-dose processing equipment, packaging machinery, inspection systems, and track-and-trace technologies. The group’s activities are organized around four principal business units: ACG Capsules, ACG Films & Foils, ACG Engineering, and ACG Inspection. ACG Capsules supplies two-piece hard gelatin capsules to pharmaceutical and nutraceutical customers in more than 100 countries and operates manufacturing facilities in India, Europe, and Brazil. ACG Films & Foils produces pharmaceutical-grade and specialty packaging materials, including high-barrier films, aluminium-based foils, polymer films, and anti-counterfeiting materials. Its stated compliance framework includes standards and regulatory references such as the US Food and Drug Administration, Canada’s drug master-file system, ISO standards, and the European Pharmacopoeia. ACG Engineering focuses on machinery for oral solid-dose pharmaceutical production. Its portfolio includes granulation equipment, capsule-filling machines, tablet presses, tablet coaters, tablet tooling, blister-packaging equipment, cartoners, and end-of-line packaging solutions. The group has reported completing more than 20,000 machine installations. ACG Inspection provides inspection and track-and-trace systems intended to support product authentication and supply-chain security. Research and technical education have also formed part of ACG’s development. In 1971, the company incorporated the SciTech Centre in Mumbai as an R&D center. The center is described as training approximately 2,000 pharmaceutical professionals annually and hosting scientific conferences. The group subsequently broadened its international footprint through acquisitions and investments. In 2007, it acquired the capsule-shell manufacturing plant of Lukaps in Croatia, described as the first establishment in Croatia by an Indian pharmaceutical-sector company. In 2017, it acquired Nova Nordeplast, a Brazilian producer of films and foils, and In2trace, a Croatia-based startup with proprietary track-and-trace technology. ACG has also pursued collaborations related to pharmaceutical security. In 2018, it signed a memorandum of understanding with Applied DNA Sciences to explore molecularly tagged empty hard-shell capsules for counterfeit prevention. The same year, ACG Inspection partnered with Verinetics to connect its track-and-trace technology with TraxSecur, a system described as using serialization and blockchain-related methods to detect supply-chain fraud. The available reference material presents ACG as an active international business with operations spanning six continents. It does not establish a public listing, current ownership structure, current chief executive, consolidated financial results, or a definitive corporate website URL. Accordingly, those fields are left unspecified.
History
ACG Group was founded in 1961 by brothers Ajit Singh and Jasjit Singh to manufacture empty hard capsules for pharmaceutical companies in India. The business began with a focused role in pharmaceutical supply, but subsequently expanded into international markets and adjacent parts of the drug-manufacturing value chain. Its later activities included capsule production, pharmaceutical packaging materials, oral solid-dose processing machinery, packaging equipment, inspection, testing, research, and development. A research and technical-training dimension was formalized in 1971, when the SciTech Centre was incorporated in Mumbai as ACG’s research and development center. The center is described as training around 2,000 pharmaceutical professionals each year and hosting scientific conferences, giving the group a role beyond equipment and materials manufacturing. ACG’s international expansion included the 2007 acquisition of the capsule-shell manufacturing plant of Lukaps in Croatia. This transaction was described as the first Croatian presence established by an Indian pharmaceutical-sector company. After improving the plant’s operations, ACG announced further expansion plans worth 50 million euros. The Croatian operation also became an export base: the reference material states that approximately 90 percent of its production was exported to the United States, Russia, and European countries. The company continued to build its packaging-materials and technology capabilities. In 2017, it acquired Nova Nordeplast, a Brazilian producer of films and foils. This broadened ACG’s geographic and product presence in specialty pharmaceutical packaging. During the same year, ACG acquired In2trace, a Croatia-based startup with proprietary track-and-trace technology. The transaction aligned with the group’s growing interest in product serialization, authentication, and supply-chain protection. ACG’s business is presented through four units. ACG Capsules manufactures two-piece hard gelatin capsules for pharmaceutical and nutraceutical applications in more than 100 countries, with facilities in India, Europe, and Brazil. ACG Films & Foils supplies specialty and high-barrier films, pharmaceutical-grade and camera-inspected aluminium foils, polymer films, and anti-counterfeiting materials. ACG Engineering supplies machinery used in oral solid-dose production, from granulation and capsule filling through tablet pressing, coating, tooling, blister packing, cartoning, and end-of-line operations. ACG Inspection supplies inspection and track-and-trace solutions. The group has pursued external collaborations to address counterfeit medicines and supply-chain fraud. In 2018, it signed a memorandum of understanding with Applied DNA Sciences to develop molecularly tagged empty hard-shell capsules. Also in 2018, ACG Inspection partnered with Verinetics to integrate its technology with TraxSecur, a software system described as combining serialization and blockchain-related systems for fraud detection. The available source describes ACG as a multinational company headquartered in Mumbai and operating in 100 countries across six continents. It does not provide sufficiently reliable information for a current executive list, ownership details, consolidated financial history, public-listing status, or a confirmed official website URL. Those details remain unspecified in this dossier.
- 2018
Anti-counterfeiting and serialization collaborations announced
[1]ACG entered a capsule-tagging development memorandum with Applied DNA Sciences and a track-and-trace integration partnership with Verinetics.
- 2017
Nova Nordeplast and In2trace acquired
[1]ACG acquired Brazilian films-and-foils producer Nova Nordeplast and Croatia-based track-and-trace startup In2trace.
- 2014
ACG Europe recognized among fast-growing Indian companies in the UK
[1]ACG Europe was listed among 41 fast-growing Indian companies in the United Kingdom, according to the cited reference.
- 2007
Lukaps plant acquired in Croatia
[1]ACG acquired Lukaps' capsule-shell manufacturing plant in Croatia and subsequently announced further expansion plans after improving its operations.
- 1971
SciTech Centre incorporated
[1]ACG incorporated the SciTech Centre in Mumbai as its research and development center; the center also became a venue for pharmaceutical training and scientific conferences.
- 1961
ACG was founded
[1]Ajit Singh and Jasjit Singh founded ACG to manufacture empty hard capsules for Indian pharmaceutical companies.
Products and positioning
An integrated global supplier for pharmaceutical and nutraceutical production, packaging, inspection, and anti-counterfeiting requirements.
Hard capsules · 1961
ACG Capsules
ACG Capsules manufactures two-piece hard gelatin capsules for pharmaceutical and nutraceutical products. The business serves customers in more than 100 countries and operates manufacturing facilities in India, Europe, and Brazil. Its capsule activities form the historical core of the group, which began by supplying empty hard capsules to Indian pharmaceutical companies. ACG has also explored molecular tagging of empty hard-shell capsules as a measure against counterfeiting.
Pharmaceutical packaging materials
ACG Films & Foils
ACG Films & Foils provides specialty packaging materials for pharmaceutical applications. Its portfolio includes high-barrier films, pharmaceutical-grade and camera-inspected aluminium foils, polymer films, and anti-counterfeiting films. The business expanded through the acquisition of Brazilian films-and-foils producer Nova Nordeplast in 2017. The cited material states that its products are aligned with requirements and standards including US FDA references, Canada-DMF, ISO standards, and the European Pharmacopoeia.
Pharmaceutical processing and packaging machinery
ACG Engineering
ACG Engineering supplies machinery for oral solid-dose pharmaceutical production. Its equipment covers granulation, capsule filling, tablet pressing, tablet coating, tablet tooling, blister packaging, cartoning, and end-of-line operations. The group has reported more than 20,000 machine installations, positioning the unit as an integrated equipment provider rather than a supplier of a single production stage.
Inspection and track-and-trace systems
ACG Inspection
ACG Inspection provides inspection and track-and-trace solutions for pharmaceutical production and distribution. Its activities include technologies associated with serialization, product identification, and supply-chain security. In 2018, the unit partnered with Verinetics to connect its technology with the TraxSecur software platform, which was described as using serialization and blockchain systems to detect fraud.
Brand decisions
2018
Develop molecularly tagged capsulesStrategyBackground
Pharmaceutical counterfeiting created demand for technologies that could authenticate dosage forms and packaging.
Action taken
ACG signed a memorandum of understanding with Applied DNA Sciences to develop molecularly tagged empty hard-shell capsules.
Aftermath
The reference confirms the development memorandum but does not establish a commercial launch or subsequent product outcome.
2018
Integrate track-and-trace technology with TraxSecurStrategyBackground
ACG Inspection sought to strengthen pharmaceutical supply-chain authentication and fraud detection.
Action taken
ACG Inspection partnered with Verinetics to integrate its track-and-trace technology with TraxSecur.
Aftermath
The partnership connected ACG’s inspection technology with software described as using serialization and blockchain systems; the reference does not report later commercial results.
2017
Expand packaging materials and track-and-trace capabilitiesM&ABackground
ACG aimed to broaden its pharmaceutical packaging-materials portfolio and add proprietary supply-chain technology.
Action taken
ACG acquired Nova Nordeplast in Brazil and In2trace in Croatia.
Aftermath
The acquisitions added films-and-foils manufacturing and track-and-trace capabilities to ACG’s four-unit business structure.
2007
Acquire the Lukaps capsule-shell plantM&ABackground
ACG sought to expand its capsule manufacturing footprint beyond India and establish a European production presence.
Action taken
ACG acquired Lukaps' capsule-shell manufacturing plant in Croatia and later announced additional expansion plans.
Aftermath
The Croatian site became an export-oriented manufacturing operation, with the cited reference stating that approximately 90 percent of its production was exported to the United States, Russia, and European countries.
Announced expansion plans. 50 million euros announced (2007)
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/acg-group · Editorial policy · How profiles are compiled